Breast Cancer Index is a predictive biomarker of treatment benefit and outcome from extended tamoxifen therapy: final analysis of the Trans-aTTom study

John M S Bartlett, Dennis C Sgroi, Kai Treuner, Yi Zhang, Tammy Piper, Ranelle C Salunga, Ikhlaaq Ahmed, Lucy Doos, Sarah Thornber, Karen J Taylor, Elena F Brachtel, Sarah J Pirrie, Catherine A Schnabel, Daniel Rea

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Breast Cancer Index is a predictive biomarker of treatment benefit and outcome from extended tamoxifen therapy: final analysis of the Trans-aTTom study'. Together they form a unique fingerprint.

Medicine & Life Sciences